Immunomodulatory nanoparticle vaccine for smoking cessation (Selecta Biosciences)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameImmunomodulatory nanoparticle vaccine for smoking cessation (Selecta Biosciences)
Drug Alias NametSVP for smoking cessation and relapse preventionSEL-068
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsSmoking Cessation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSelecta Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSelecta Biosciences Inc
Active IndicationsN/A
Inactive IndicationsSmoking Cessation

Other Information

ATC CodeN/A
Related LinksN/A